Skip to main content

Articles

Page 82 of 87

  1. This study evaluated the efficacy and safety of the long-acting β2-agonist formoterol in patients with moderate-to-severe COPD.

    Authors: Miron A Bogdan, Hisamichi Aizawa, Yoshinosuke Fukuchi, Michiaki Mishima, Masaharu Nishimura and Masakazu Ichinose
    Citation: BMC Pulmonary Medicine 2011 11:51
  2. There are only a few follow-up studies of respiratory function among cement workers. The main aims of this study were to measure total dust exposure, to examine chronic respiratory symptoms and changes in lung...

    Authors: Zeyede K Zeleke, Bente E Moen and Magne Bråtveit
    Citation: BMC Pulmonary Medicine 2011 11:50
  3. Hospital readmission for acute exacerbation of COPD (AECOPD) occurs in up to 30% of patients, leading to excess morbidity and poor survival. Physiological risk factors predict readmission, but the impact of mo...

    Authors: Peter A Coventry, Isla Gemmell and Christopher J Todd
    Citation: BMC Pulmonary Medicine 2011 11:49
  4. Although anti-asthma medications are amongst those most frequently under or over prescribed it is generally accepted that prescriptions for such agents can be used as a proxy for disease prevalence. The aims o...

    Authors: Marina Bianchi, Antonio Clavenna, Marco Sequi,, Angela Bortolotti, Ida Fortino, Luca Merlino and Maurizio Bonati
    Citation: BMC Pulmonary Medicine 2011 11:48
  5. Recent studies find that a considerable number of patients with pulmonary arterial hypertension (PAH) develop fibrous obstruction of the pulmonary veins. Such obstruction more commonly accompanies connective t...

    Authors: Yasuko Takeda, Yutaka Takeda, Koji Yamamoto, Shigehiro Tomimoto, Tomomitsu Tani, Hitomi Narita, Nobuyuki Ohte and Genjiro Kimura
    Citation: BMC Pulmonary Medicine 2011 11:47
  6. An increased incidence of pneumonia in patients with chronic obstructive pulmonary disease (COPD) under inhaled corticosteroid (ICS) therapy was noticed in previous studies. We performed a prospective study to...

    Authors: Shih-Lung Cheng, Hao-Chien Wang, Shih-Jung Cheng and Chong-Jen Yu
    Citation: BMC Pulmonary Medicine 2011 11:46
  7. Little is known of how mucociliary clearance (MCC) in children with cystic fibrosis (CF) and normal pulmonary function compares with healthy adults, or how an acute inhalation of 7% hypertonic saline (HS) aero...

    Authors: Beth L Laube, Gail Sharpless, Kathryn A Carson, Amber Kelly and Peter J Mogayzel Jr
    Citation: BMC Pulmonary Medicine 2011 11:45
  8. Inflammation, both local and systemic, is a hallmark of chronic obstructive pulmonary disease (COPD). Inflammatory mediators such as TNFα and GM-CSF are secreted by lung epithelium, alveolar macrophages and ot...

    Authors: Jeroen D Langereis, René C Schweizer, Jan-Willem J Lammers, Leo Koenderman and Laurien H Ulfman
    Citation: BMC Pulmonary Medicine 2011 11:44
  9. Although timely treatment of COPD exacerbations seems clinically important, nearly half of these exacerbations remain unreported and subsequently untreated. Recent studies have investigated incidence and impac...

    Authors: Jaap CA Trappenburg, David Schaap, Evelyn M Monninkhof, Jean Bourbeau, Gerdien H de Weert-van Oene, Theo JM Verheij, Jan-Willem J Lammers and Augustinus JP Schrijvers
    Citation: BMC Pulmonary Medicine 2011 11:43
  10. The COPD Assessment Test (CAT™) is a new short health status measure for routine use. New questionnaires require reference points so that users can understand the scores; descriptive scenarios are one way of d...

    Authors: Paul W Jones, Margaret Tabberer and Wen-Hung Chen
    Citation: BMC Pulmonary Medicine 2011 11:42
  11. Tachykinins substance P, neurokinin A and neurokinin B seem to account for asthma pathophysiology by mediating neurogenic inflammation and several aspects of lung mechanics. These neuropeptides act mainly by t...

    Authors: Renata Ramalho, Raquel Soares, Nuno Couto and André Moreira
    Citation: BMC Pulmonary Medicine 2011 11:41
  12. Although patients have more problems using metered dose inhalers, clinical comparisons suggest they provide similar control to dry powder inhalers. Using real-life situations this study was designed to evaluat...

    Authors: Veronika Müller, Gabriella Gálffy, Noemi Eszes, György Losonczy, Andrea Bizzi, Gabriele Nicolini, Henry Chrystyn and Lilla Tamási
    Citation: BMC Pulmonary Medicine 2011 11:40
  13. Neuropeptide S Receptor 1 (NPSR1, GPRA, GPR154) was first identified as an asthma candidate gene through positional cloning and has since been replicated as an asthma and allergy susceptibility gene in several in...

    Authors: Christina Orsmark Pietras, Johanna Vendelin, Francesca Anedda, Sara Bruce, Mikael Adner, Lilli Sundman, Ville Pulkkinen, Harri Alenius, Mauro D'Amato, Cilla Söderhäll and Juha Kere
    Citation: BMC Pulmonary Medicine 2011 11:39
  14. Acute bronchitis is one of the most prevalent respiratory infections in primary care, and in more than 90% of the cases antibiotics are prescribed, mainly when purulent expectoration is present. However, this ...

    Authors: Carl Llor, Ana Moragas, Carolina Bayona, Rosa Morros, Helena Pera, Josep M Cots, Yvonne Fernández, Marc Miravitlles and Albert Boada
    Citation: BMC Pulmonary Medicine 2011 11:38
  15. Little is known about the effect of smoking cessation on airway inflammation. Secretory Leukocyte Protease Inhibitor (SLPI), Clara Cell protein 16 (CC16), elafin and human defensin beta-2 (HBD-2) protect human...

    Authors: Izolde Bouloukaki, Ioanna G Tsiligianni, Maria Tsoumakidou, Ioanna Mitrouska, Emmanuel P Prokopakis, Irene Mavroudi, Nikolaos M Siafakas and Nikolaos Tzanakis
    Citation: BMC Pulmonary Medicine 2011 11:35
  16. The World Health Organization has estimated that by 2030, chronic obstructive pulmonary disease will be the third leading cause of death worldwide. Most knowledge of chronic obstructive pulmonary disease is ba...

    Authors: Adolfo L Rubinstein, Vilma E Irazola, Lydia A Bazzano, Edgardo Sobrino, Matías Calandrelli, Fernando Lanas, Alison G Lee, Jose A Manfredi, Héctor Olivera, Jacqueline Ponzo, Pamela Seron and Jiang He
    Citation: BMC Pulmonary Medicine 2011 11:34
  17. Despite its widespread use in pulmonary fibrosis research, the bleomycin mouse model has not been thoroughly validated from a pulmonary functional standpoint using new technologies. Purpose of this study was t...

    Authors: Effrosyni D Manali, Charalampos Moschos, Christina Triantafillidou, Anastasia Kotanidou, Ioannis Psallidas, Sophia P Karabela, Charis Roussos, Spyridon Papiris, Apostolos Armaganidis, Georgios T Stathopoulos and Nikolaos A Maniatis
    Citation: BMC Pulmonary Medicine 2011 11:33
  18. Asthma is difficult to diagnose in children and at times misdiagnosis of an infection can occur. However, little is known about the magnitude and patterns of antibiotic consumption in children with asthma rela...

    Authors: Fawziah Marra, Carlo A Marra, Kathryn Richardson, Larry D Lynd and Mark J FitzGerald
    Citation: BMC Pulmonary Medicine 2011 11:32
  19. Indacaterol is a novel once-daily ultra long-acting β2-agonist for the treatment of chronic obstructive pulmonary disease. It is known that β2-agonists, like other adrenergic compounds, can prolong the QT-interva...

    Authors: Sanjeev Khindri, Ronald Sabo, Stuart Harris, Ralph Woessner, Simon Jennings and Anton F Drollmann
    Citation: BMC Pulmonary Medicine 2011 11:31
  20. Pulmonary hypertension (PH) is a life-threatening disease with poor prognosis. Encouraging efforts have been made to target the main vasoproliferative aspects of the disease. Promising emerging therapeutics ar...

    Authors: Jan K Hennigs, Gunhild Keller, Hans Jörg Baumann, Friedemann Honecker, Stefan Kluge, Carsten Bokemeyer, Tim H Brümmendorf and Hans Klose
    Citation: BMC Pulmonary Medicine 2011 11:30
  21. The role of microRNAs (miRNAs) in regulating gene expression is currently an area of intense interest. Relatively little is known, however, about the role of miRNAs in inflammatory and immunologically-driven d...

    Authors: Adam Collison, Cristan Herbert, Jessica S Siegle, Joerg Mattes, Paul S Foster and Rakesh K Kumar
    Citation: BMC Pulmonary Medicine 2011 11:29
  22. The inhaled corticosteroid (ICS) fluticasone propionate (fluticasone) and the long-acting β2-agonist (LABA) formoterol fumarate (formoterol) are being made available as a combination product (fluticasone/formoter...

    Authors: Anna Bodzenta-Lukaszyk, Andrzej Dymek, Kirsten McAulay and Heikki Mansikka
    Citation: BMC Pulmonary Medicine 2011 11:28
  23. The prevalence of physician-diagnosed-asthma has risen over the past three decades and misdiagnosis of asthma is potentially common. Objective: to determine whether a secondary-screening-program to establish a...

    Authors: Smita Pakhale, Amanda Sumner, Douglas Coyle, Katherine Vandemheen and Shawn Aaron
    Citation: BMC Pulmonary Medicine 2011 11:27
  24. Human Immunodeficiency Virus (HIV) infection predisposes to tuberculosis (TB). We described incidence, risk factors and prognosis of TB in HIV-1 infected patients during pre (1995-1996), early (1997-1999), and...

    Authors: Gry A Taarnhøj, Frederik N Engsig, Pernille Ravn, Isik S Johansen, Carsten S Larsen, Birgit Røge, Aase B Andersen and Niels Obel
    Citation: BMC Pulmonary Medicine 2011 11:26
  25. Advances in the understanding and management of pulmonary arterial hypertension have enabled earlier diagnosis and improved prognosis. However, despite best available therapy, symptoms of exertional dyspnoea a...

    Authors: Louise Ganderton, Sue Jenkins, Kevin Gain, Robin Fowler, Peta Winship, Dianne Lunt and Eli Gabbay
    Citation: BMC Pulmonary Medicine 2011 11:25
  26. The prevalence of allergic diseases has increased over recent decades in affluent countries, but remains low in rural populations and some non-affluent countries. An explanation for these trends is that increa...

    Authors: Rafael V Veiga, Sergio S Cunha, Vitor CC Dattoli, Álvaro C Cruz, Phillip J Cooper, Laura C Rodrigues, Maurício L Barreto and Neuza M Alcantara-Neves
    Citation: BMC Pulmonary Medicine 2011 11:24
  27. KL-6 is a high-molecular-weight glycoprotein classified as a human MUC1 mucin. It was hypothesized that KL-6 could be detectable in the circulating blood and especially in airway secretions in lung diseases as...

    Authors: Nobuhisa Ishikawa, Witold Mazur, Tuula Toljamo, Katri Vuopala, Mikko Rönty, Yasushi Horimasu, Nobuoki Kohno and Vuokko L Kinnula
    Citation: BMC Pulmonary Medicine 2011 11:22
  28. To produce a conceptually equivalent Arabic version to the original Self-Administered Chronic Respiratory Disease Questionnaire with standardized dyspnea domain (CRQ-SAS) and to assess its reliability.

    Authors: Mohamed S Al Moamary and Hani M Tamim
    Citation: BMC Pulmonary Medicine 2011 11:21
  29. Patients with COPD have an increased risk of cardiovascular disease. Whilst pulmonary rehabilitation has proven benefit for exercise tolerance and quality of life, any effect on cardiovascular risk has not bee...

    Authors: Nichola S Gale, James M Duckers, Stephanie Enright, John R Cockcroft, Dennis J Shale and Charlotte E Bolton
    Citation: BMC Pulmonary Medicine 2011 11:20
  30. A significant number of young people start smoking at an age of 13-15, which means that serious smoking-evoked changes may have been occurred by their twenties. Surfactant proteins (SP) and matrix metalloprote...

    Authors: Helen Ilumets, Witold Mazur, Tuula Toljamo, Noora Louhelainen, Pentti Nieminen, Hideo Kobayashi, Nobuhisa Ishikawa and Vuokko L Kinnula
    Citation: BMC Pulmonary Medicine 2011 11:19
  31. The relationships between total serum IgE levels and gene expression patterns in peripheral blood CD4+ T cells (in all subjects and within each sex specifically) are not known.

    Authors: Gary M Hunninghake, Jen-hwa Chu, Sunita S Sharma, Michael H Cho, Blanca E Himes, Angela J Rogers, Amy Murphy, Vincent J Carey and Benjamin A Raby
    Citation: BMC Pulmonary Medicine 2011 11:17
  32. The immune modulating properties of statins may benefit smokers with asthma. We tested the hypothesis that short-term treatment with atorvastatin improves lung function or indices of asthma control in smokers ...

    Authors: Georgina Braganza, Rekha Chaudhuri, Charles McSharry, Christopher J Weir, Iona Donnelly, Lisa Jolly, Jane Lafferty, Suzanne M Lloyd, Mark Spears, Frances Mair and Neil C Thomson
    Citation: BMC Pulmonary Medicine 2011 11:16
  33. Direct smear examination with Ziehl-Neelsen (ZN) staining for the diagnosis of pulmonary tuberculosis (PTB) is cheap and easy to use, but its low sensitivity is a major drawback, particularly in HIV seropositi...

    Authors: Luciene C Scherer, Rosa D Sperhacke, Carla Jarczewski, Patrícia I Cafrune, Candice T Michelon, Rubia Rupenthal, Marta Osorio Ribeiro, Antonio Ruffino Netto, Maria LR Rossetti and Afrânio L Kritski
    Citation: BMC Pulmonary Medicine 2011 11:15
  34. Interleukin-9 (IL-9)-targeted therapies may offer a novel approach for treating asthmatics. Two randomized placebo-controlled studies were conducted to assess the safety profile and potential efficacy of multi...

    Authors: Joseph M Parker, Chad K Oh, Craig LaForce, S David Miller, David S Pearlman, Chenxiong Le, Gabriel J Robbie, Wendy I White, Barbara White and Nestor A Molfino
    Citation: BMC Pulmonary Medicine 2011 11:14
  35. Chronic obstructive pulmonary disease (COPD) remains a major public health problem that affects the quality of life of patients, however smoking cessation may emeliorate the functional effects of COPD and alte...

    Authors: George Papadopoulos, Constantine I Vardavas, Maria Limperi, Apostolos Linardis, George Georgoudis and Panagiotis Behrakis
    Citation: BMC Pulmonary Medicine 2011 11:13
  36. Endotoxins are ubiquitously present in the environment and constitute a significant component of ambient air. These substances have been shown to modulate the allergic response, however a consensus has yet to ...

    Authors: Sudha Natarajan, Jiyoun Kim, Jacqueline Bouchard, William Cruikshank and Daniel G Remick
    Citation: BMC Pulmonary Medicine 2011 11:12
  37. In mechanically ventilated preterm infants with respiratory distress syndrome (RDS), exogenous surfactant application has been demonstrated both to decrease DNA-synthesis but also and paradoxically to increase...

    Authors: Andreas Wemhöner, Paul Jennings, Thomas Haller, Mario Rüdiger and Georg Simbruner
    Citation: BMC Pulmonary Medicine 2011 11:11
  38. Progressive airway inflammation and susceptibility to the airway colonisation and infection are characteristic for the pathophysiology of chronic obstructive pulmonary disease (COPD). Antimicrobial peptides (A...

    Authors: Ellen Andresen, Christoph Lange, Daniela Strodthoff, Torsten Goldmann, Nicole Fischer, Hany Sahly, Detlev Branscheid and Holger Heine
    Citation: BMC Pulmonary Medicine 2011 11:10
  39. Patients with COPD on long term oxygen therapy frequently do not adhere to their prescription, and they frequently do not use their ambulatory oxygen systems as intended. Reasons for this lack of adherence are...

    Authors: Elizabeth Arnold, Anne Bruton, Maggie Donovan-Hall, Angela Fenwick, Bridget Dibb and Elizabeth Walker
    Citation: BMC Pulmonary Medicine 2011 11:9
  40. Bronchial thermoplasty (BT) is a bronchoscopic procedure that improves asthma control by reducing excess airway smooth muscle. Treated patients have been followed out to 5 years to evaluate long-term safety of...

    Authors: Neil C Thomson, Adalberto S Rubin, Robert M Niven, Paul A Corris, Hans Christian Siersted, Ronald Olivenstein, Ian D Pavord, David McCormack, Michel Laviolette, Narinder S Shargill and Gerard Cox
    Citation: BMC Pulmonary Medicine 2011 11:8
  41. Therapeutic adherence of patients with chronic obstructive pulmonary disease (COPD) is poor. It is therefore necessary to determine the magnitude of non-adherence to develop strategies to correct this behaviou...

    Authors: Pilar Barnestein-Fonseca, José Leiva-Fernández, Francisca Vidal-España, Antonio García-Ruiz, Daniel Prados-Torres and Francisca Leiva-Fernández
    Citation: BMC Pulmonary Medicine 2011 11:6
  42. Adherence with tobramycin inhalation solution (TIS) during routine cystic fibrosis (CF) care may differ from recommended guidelines and affect health care utilization.

    Authors: Becky A Briesacher, Alexandra L Quittner, Lisa Saiman, Patricia Sacco, Hassan Fouayzi and Lynne M Quittell
    Citation: BMC Pulmonary Medicine 2011 11:5
  43. A key strategy in improving care for people with chronic obstructive pulmonary disease (COPD) is the provision of pulmonary rehabilitation programmes. Pulmonary rehabilitation programmes have been successful i...

    Authors: Kathy Murphy, Dympna Casey, Declan Devane, Adeline Cooney, Bernard McCarthy, Lorraine Mee, Martina Nichulain, Andrew W Murphy, John Newell and Eamon O' Shea
    Citation: BMC Pulmonary Medicine 2011 11:4
  44. Chemical irritation of airway mucosa elicits a variety of reflex responses such as coughing, apnea, and laryngeal closure. Inhaled irritants can activate either chemosensitive free nerve endings, laryngeal tas...

    Authors: Marco Tizzano, Mirko Cristofoletti, Andrea Sbarbati and Thomas E Finger
    Citation: BMC Pulmonary Medicine 2011 11:3
  45. Since the first outbreak of a respiratory illness caused by H1N1 virus in Mexico, several reports have described the need of intensive care or extracorporeal membrane oxygenation (ECMO) assistance in young and...

    Authors: Giovanni Cianchi, Manuela Bonizzoli, Andrea Pasquini, Massimo Bonacchi, Giovanni Zagli, Marco Ciapetti, Guido Sani, Stefano Batacchi, Simona Biondi, Pasquale Bernardo, Chiara Lazzeri, Valtere Giovannini, Alberta Azzi, Rosanna Abbate, Gianfranco Gensini and Adriano Peris
    Citation: BMC Pulmonary Medicine 2011 11:2

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.0
    Source Normalized Impact per Paper (SNIP): 0.889
    SCImago Journal Rank (SJR): 0.773

    Speed 2024
    Submission to first editorial decision (median days): 19
    Submission to acceptance (median days): 142

    Usage 2024
    Downloads: 3,010,764
    Altmetric mentions: 1,119

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal